A Clinical Study Comparing a Traditional Herbal Remedy (Vishwa-Eladi Yog) with Norethisterone for Managing Heavy Menstrual Bleeding (Asrigdara)

RANDOMISED CONTROLLED CLINICAL STUDY TO EVALUATE THE EFFECT OF VISHWA-ELADI YOG IN COMPARISON WITH NORETHISTERONE IN MANAGEMENT OF ASRIGDARA - Nil

Status

Recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/07/091249

Enrollment

Registered

2025-07-21

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N719- Inflammatory disease of uterus, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age Group: Women between 25â??40 years. 2. Menstrual Duration: Bleeding for more than 7 days per cycle. 3. Blood Loss Volume: More than 80 mL or more than 3 pads per day. 4. Cycle Frequency: Polymenorrhea â?? Intermenstrual period less than 21 days. 5. Diagnosed conditions including: Fibroid Endometriosis Adenomyosis

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Reduction in the amount of menstrual blood loss.Timepoint: 8 weeks	—

Secondary

Measure	Time frame
1. Improvement in associated symptoms (such as pain, fatigue, or weakness). 2. Changes in hemoglobin levels (to assess improvement in anemia due to bleeding). 3. Changes in menstrual cycle regularity. 4. Improvement in quality of life scores (using a standardized questionnaire). 5. Adverse effects or side effects of both interventions. 6. Patient satisfaction and compliance. 7. Effect on hormonal profile (if applicable, such as estrogen/progesterone levels). 8. Duration of therapeutic effect after discontinuation of treatment.Timepoint: 3 month	—

Measure

Time frame

1. Improvement in associated symptoms (such as pain, fatigue, or weakness). 2. Changes in hemoglobin levels (to assess improvement in anemia due to bleeding). 3. Changes in menstrual cycle regularity. 4. Improvement in quality of life scores (using a standardized questionnaire). 5. Adverse effects or side effects of both interventions. 6. Patient satisfaction and compliance. 7. Effect on hormonal profile (if applicable, such as estrogen/progesterone levels). 8. Duration of therapeutic effect after discontinuation of treatment.Timepoint: 3 month

—

Countries

India

Contacts

Public ContactDr Kajal Dnyanadev Saste

Tilak ayurvedic mahavidyalaya rasta peth pune

drrahulgarudkar@yahoo.com9822777367

Outcome results